Skip to main content
. 2022 May 27;14(5):429–441. doi: 10.4240/wjgs.v14.i5.429

Table 1.

Patient demographics, operative and pathological characteristics and outcomes

Factors
Total (n = 81)
PALN+ (n = 17)
PALN- (n = 64)
P value
Demographics
Age (median and range in years) 69 (43-84) 68.8 (61-72.3) 69 (61-75) 0.404
Gender, male (%) 38 (47) 12 (71) 33 (52) 0.171
BMI (kg/m2) 25.1 (22.0-27.8) 26.2 (22.2-27.8) 24.9 (21.9-27.7) 0.413
Non-smoker (%) 13 (73) 14 (82) 46 (72) 0.462
Preoperative CA19-9 levels (KU/L) 286 (2-36000) 410 (14-2784) 252 (2-36000) 0.594
Charlson comorbidity index 4 (3-5) 4 (3-5) 4.5 (3-5) 0.079
Preoperative radiological stage n (%)
Resectable 41 (51) 8 (47) 33 (52) 0.601
Borderline resectable 31 (38) 8(47) 23 (36)
Locally advanced 9 (11) 1 (6) 8 (12)
Operation, n (%)
Distal pancreatectomy 1 (1) 0 1 (1) 0.681
Total pancreatectomy 14 (17) 2 (12) 12 (19)
Pancreaticoduodenectomy 66 (82) 15 (88) 51 (80)
Vein resection 33 (41) 7 (41) 26 (41) 0.310
Arterial resection 3 (4) 1 (6) 2 (3) 0.842
Pathological staging, n (%) 1.000
pT1 13 (16) 3 (18) 10 (16) 0.951
pT2 46 (57) 9 (53) 37 (58)
pT3 21 (26) 5 (29) 16 (25)
pT4 1 (1) 0 1 (1)
pN0 14 (79) 0 14 (22) 0.005
pN1 24 (30) 3 (18) 21 (33)
pN2 43 (53) 14 (82) 29 (45)
Resection margin, n (%)
Negative 39 (48) 6 (35) 33 (52) 0.282
Positive 42 (52) 11 (65) 31 (48)
Perineural invasion 66 (83) 15 (88) 51 (80) 0.722
Perivascular invasion 59 (73) 13 (77) 46 (72) 1.000
Chemotherapy, n (%) 55 (74) 12 (71) 43 (67) 0.746
Neoadjuvant therapy 13 (16) 2 (12) 11 (17) 0.726
Adjuvant chemotherapy 49 (66) 12 (71) 37 (58) 0.553
Post-operative complications, n (%)
Clavien Dindo category ≥ 3 10 (12) 2 (11.8) 8 (12.5) 0.549
Chyle leak 1 (1) 0 1 (1.56) 0.835
Perioperative haemorrhage 2 (2) 0 2 (3.13) 0.712
Comprehensive complication index 0 (0-20.9) 0 (0-20.9) 0 (0-20.9) 0.083
Hospital length of stay (median and range in days) 9 (1-76) 8 (5-30) 10 (1-76) 0.138

BMI: Body mass index; PALN: Para-aortic lymph nodes.